These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30611093)

  • 1. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.
    Massa F; Arnaldi D; De Cesari F; Girtler N; Brugnolo A; Grazzini M; Bauckneht M; Meli R; Morbelli S; Pardini M; Sambuceti G; De Carli F; Tiraboschi P; Nobili F
    Neurobiol Aging; 2019 Apr; 76():9-17. PubMed ID: 30611093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
    Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
    Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
    Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
    Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Iizuka T; Kameyama M
    Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.
    Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Colloby SJ; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Psychol Med; 2018 Oct; 48(14):2384-2390. PubMed ID: 29362011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
    Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
    Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
    Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
    Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
    Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.
    Takemoto M; Sato K; Hatanaka N; Yamashita T; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016; 52(1):205-11. PubMed ID: 27060948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
    Chang CC; Liu JS; Chang YY; Chang WN; Chen SS; Lee CH
    Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
    Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
    Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies.
    Berman SB; Miller-Patterson C
    Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies.
    Thomas AJ; Donaghy P; Roberts G; Colloby SJ; Barnett NA; Petrides G; Lloyd J; Olsen K; Taylor JP; McKeith I; O'Brien JT
    Psychol Med; 2019 Feb; 49(3):396-402. PubMed ID: 29692275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Microbleeds in Patients with Parkinson's Disease and Dementia with Lewy Bodies: Comparison Using Magnetic Resonance Imaging and 99 mTc-ECD SPECT Subtraction Imaging.
    Takemoto M; Yamashita T; Ohta Y; Tadokoro K; Omote Y; Morihara R; Abe K
    J Alzheimers Dis; 2021; 80(1):331-335. PubMed ID: 33523013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.